Rejuvel Bio-Sciences, Inc. (NUUU) financial statements (2021 and earlier)

Company profile

Business Address CHASE BANK BUILDING 150 SE 2ND AVE
MIAMI, FL 33131
State of Incorp. FL
Fiscal Year End December 31
SIC 519 - Miscellaneous Non-durable Goods (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments405121
Cash and cash equivalents405121
Inventory, net of allowances, customer advances and progress billings571125
Inventory571125
Prepaid expense and other current assets24
Other current assets2 
Other undisclosed current assets7750
Total current assets:5385300
Noncurrent Assets
Property, plant and equipment624026
Intangible assets, net (including goodwill)1622
Intangible assets, net (excluding goodwill)1622
Other undisclosed noncurrent assets(26)(20)(12)
Total noncurrent assets:522116
TOTAL ASSETS:105106315
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:459344194
Other undisclosed accounts payable and accrued liabilities459344194
Derivative instruments and hedges, liabilities49350276
Due to related parties777789
Deferred revenue and credits3  
Other undisclosed current liabilities350436 
Total current liabilities:9381,207559
Noncurrent Liabilities
Other undisclosed liabilities  224
Total liabilities:9381,207782
Stockholders' equity
Stockholders' equity attributable to parent(833)(1,101)(467)
Common stock50117117
Additional paid in capital1,274586505
Accumulated deficit(2,158)(1,805)(1,089)
Total stockholders' equity:(833)(1,101)(467)
TOTAL LIABILITIES AND EQUITY:105106315

Income statement (P&L) ($ in thousands)

12/31/2014
12/31/2013
12/31/2012
Revenues94528
Cost of revenue(83)(27)(4)
Gross profit:11254
Operating expenses(814)(653)(766)
Other undisclosed operating income7359984
Operating loss:(69)(530)(678)
Nonoperating expense
(Investment Income, Nonoperating)
(267)  
Interest and debt expense99(196)(153)
Net loss:(237)(726)(831)
Other undisclosed net income (loss) attributable to parent(116)11(3)
Net loss available to common stockholders, diluted:(353)(716)(834)

Comprehensive Income ($ in thousands)

12/31/2014
12/31/2013
12/31/2012
Net loss:(237)(726)(831)
Comprehensive loss, net of tax, attributable to parent:(237)(726)(831)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: